Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Block listing Interim Review

9th Sep 2025 18:28

RNS Number : 6753Y
Advanced Medical Solutions Grp PLC
09 September 2025
 

 

9 September 2025

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1. Deferred Share Bonus Scheme

2. Enterprise Management Incentive Scheme

3. Company Share Option Plan

4. Unapproved Executive Share Option Scheme

5. Long Term Incentive Plan

6. Deferred Annual Bonus Scheme

Period of return:

From:

6 March 2025

To:

5 September 2025

Balance of unallotted securities under scheme(s) from previous return:

1. 1,739

2. Nil

3. 129,543

4. 167,103

5. 13,886

6. 245,821

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 1,739

2. Nil

3. 41,970

4. 82,562

5. 13,886

6. 16,059

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. Nil

2. Nil

3. 87,573

4. 84,541

5. Nil

6. 229,762

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018.

 

 

Name of contact:

Owen Bromley

Telephone number of contact:

01606 545514

 

 

For further information, please visit www.admedsol.com or contact:

 

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations

 

Optimum Strategic Communications

Tel: +44 (0) 20 4566 8543

Mary Clark / Nick Bastin / Isabelle Abdou

[email protected]

Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Gary Clarence / David Anderson

Berenberg (Joint Broker)

Tel: +44 (0) 20 3207 7800

Toby Flaux / Detlir Elezi / Yasmina Benchekroun

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRUPUQPBUPAGMB

Related Shares:

Advanced Medical Solutions Group
FTSE 100 Latest
Value9,283.16
Change-0.13